PT Prodia Diagnostic Line Tbk (IDX:PRDL)
Indonesia · Delayed Price · Currency is IDR 107.00
-1.00 (-0.93%)
Last updated: Nov 4, 2026, 2:59 PM WIB
IDX:PRDL Revenue
PT Prodia Diagnostic Line Tbk had revenue of 7.78B IDR in the quarter ending September 30, 2026, a decrease of -45.34%. This brings the company's total for the last twelve months to 40.87B. In the year 2025, PT Prodia Diagnostic Line Tbk had annual revenue of 74.37B with 26.79% growth. That makes PT Prodia Diagnostic Line Tbk the 42,160th largest company in the world by revenue and 815th in Indonesia.
Revenue (ttm)
40.87B
Revenue Growth
+26.79%
P/S Ratio
3.16
Revenue / Employee
648.69M
Employees
63
Market Cap
130.54B
Revenue by Segment
- Clinical Chemistry 60.38B 81.2%
- Instrument 8.83B 11.9%
- Hematology 4.09B 5.5%
- Services 1.02B 1.4%
- Immunology & Biomoleculer 56.57M 0.1%
Fiscal year ended Dec 31, 2025 See the full IDX:PRDL breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 74.37B | 15.71B | 26.79% |
| Dec 31, 2024 | 58.66B | -53.12B | -47.52% |
| Dec 31, 2023 | 111.78B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.